NEU1’s involvement in several metabolic diseases has been reviewed previously, highlighting its complex regulatory effects on insulin signaling, obesity, and non-alcoholic fatty liver disease (NAFLD) [59]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.